Analysts See $2.08 EPS for Express Scripts Holding Company (ESRX); Angiodynamics (ANGO)’s Sentiment Is 1.17

January 18, 2018 - By Marie Mckinney

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company has market cap of $595.53 million. The firm provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; Asclera drug for treating uncomplicated spider and reticular veins of the lower extremities; and Sotradecol drugs for treating small uncomplicated varicose veins of the lower extremities. It currently has negative earnings. It also offers AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support.

Analysts expect Express Scripts Holding Company (NASDAQ:ESRX) to report $2.08 EPS on February, 13.They anticipate $0.20 EPS change or 10.64% from last quarter’s $1.88 EPS. ESRX’s profit would be $1.18B giving it 9.64 P/E if the $2.08 EPS is correct. After having $1.90 EPS previously, Express Scripts Holding Company’s analysts see 9.47% EPS growth. The stock decreased 0.71% or $0.57 during the last trading session, reaching $80.21. About 119,019 shares traded. Express Scripts Holding Company (NASDAQ:ESRX) has declined 16.92% since January 18, 2017 and is downtrending. It has underperformed by 33.62% the S&P500.

Ratings analysis reveals 50% of AngioDynamics’s analysts are positive. Out of 2 Wall Street analysts rating AngioDynamics, 1 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. ANGO was included in 2 notes of analysts from November 4, 2016. Barclays Capital initiated the stock with “Equal Weight” rating in Wednesday, February 8 report. The stock of AngioDynamics, Inc. (NASDAQ:ANGO) has “Buy” rating given on Friday, November 4 by Cantor Fitzgerald.

The stock decreased 0.98% or $0.16 during the last trading session, reaching $16.22. About 2,619 shares traded. AngioDynamics, Inc. (ANGO) has risen 31.47% since January 18, 2017 and is uptrending. It has outperformed by 14.77% the S&P500.

Broadfin Capital Llc holds 4.48% of its portfolio in AngioDynamics, Inc. for 1.77 million shares. Lapides Asset Management Llc owns 473,300 shares or 1.66% of their US portfolio. Moreover, Perkins Capital Management Inc has 0.87% invested in the company for 48,650 shares. The Connecticut-based Thomson Horstmann & Bryant Inc has invested 0.7% in the stock. Lucus Advisors Llc, a New York-based fund reported 19,250 shares.

Investors sentiment increased to 0.62 in 2017 Q3. Its up 0.06, from 0.56 in 2017Q2. It improved, as 66 investors sold Express Scripts Holding Company shares while 414 reduced holdings. 72 funds opened positions while 224 raised stakes. 486.80 million shares or 2.59% less from 499.72 million shares in 2017Q2 were reported. 5,372 were accumulated by Everett Harris Ca. Peoples Fincl Service holds 0.09% or 2,600 shares. S&T Bank Pa has invested 1.1% in Express Scripts Holding Company (NASDAQ:ESRX). Prudential Public Limited invested in 0% or 12,043 shares. Legg Mason Asset Management (Japan) Communications stated it has 14,200 shares. Creative Planning invested 0.02% of its portfolio in Express Scripts Holding Company (NASDAQ:ESRX). Asset Advsrs has 0.11% invested in Express Scripts Holding Company (NASDAQ:ESRX). Spears Abacus Advsrs Limited Company invested in 0.02% or 3,245 shares. 12,660 are owned by Lipe And Dalton. Archford Capital Strategies Ltd Liability holds 0.1% of its portfolio in Express Scripts Holding Company (NASDAQ:ESRX) for 4,073 shares. Brighton Jones Lc reported 14,494 shares. Valley National Advisers Incorporated, Pennsylvania-based fund reported 551 shares. The Colorado-based Milestone Grp has invested 0.03% in Express Scripts Holding Company (NASDAQ:ESRX). Andra Ap owns 88,900 shares. Bbva Compass State Bank invested in 0.03% or 8,116 shares.

Express Scripts Holding Company operates as a pharmacy benefit management firm in the United States, Canada, and Europe. The company has market cap of $45.43 billion. It operates in two divisions, PBM and Other Business Operations. It has a 13.17 P/E ratio. The PBM segment offers clinical solutions, specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, administration of a group purchasing organization, and consumer health and drug information services.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.